Rockefeller Capital Management
BLUE

Rockefeller Capital Management’s bluebird bio BLUE Stock Holding History

Rockefeller Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed – – 2204
2022
Q4 		$0 Hold
1
– – ﹤0.01% 3862
2022
Q3 		$0 Sell
1
-3
-75% -$339 ﹤0.01% 3891
2022
Q2 		$0 Buy
+4
New +$310 ﹤0.01% 4102
2021
Q4 		– Sell
-137
Closed -$33K – 3773
2021
Q3 		$33K Buy
137
+6
+5% +$1.72K ﹤0.01% 2337
2021
Q2 		$54K Buy
131
+16
+14% +$6.34K ﹤0.01% 2038
2021
Q1 		$45K Sell
115
-344
-75% -$169K ﹤0.01% 1926
2020
Q4 		$256K Sell
459
-8
-2% -$5.07K ﹤0.01% 1113
2020
Q3 		$326K Sell
467
-383
-45% -$299K ﹤0.01% 912
2020
Q2 		$672K Buy
850
+738
+659% +$557K 0.01% 622
2020
Q1 		$67K Buy
112
+4
+4% +$3.9K ﹤0.01% 1146
2019
Q4 		$122K Hold
108
– – ﹤0.01% 909
2019
Q3 		$128K Hold
108
– – ﹤0.01% 723
2019
Q2 		$177K Hold
108
– – ﹤0.01% 595
2019
Q1 		$221K Hold
108
– – ﹤0.01% 584
2018
Q4 		$138K Buy
+108
New +$166K ﹤0.01% 427

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Rockefeller Capital Management's BLUE Position: Q1 2023 in Review

Rockefeller Capital Management sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 1 share.

Rockefeller Capital Management first reported a position in BLUE in Q4 2018 and held it in 15 quarters. The position peaked at $672K in Q2 2020. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • Rockefeller Capital Management reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 1 bluebird bio share in Q1 2023.
  • Rockefeller Capital Management first reported a position in bluebird bio in Q4 2018 and held it in 15 quarters.
  • Rockefeller Capital Management's bluebird bio position peaked at $672K in Q2 2020.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.